BRPI0607701A2 - composto ou um sal, éster, solvato, estereoisÈmero, tautÈmero ou pró-droga farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de uma quantidade antibacterialmente eficaz de um composto junto com um veìculo farmaceuticamente aceitável, e, método de preparação de um composto - Google Patents

composto ou um sal, éster, solvato, estereoisÈmero, tautÈmero ou pró-droga farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de uma quantidade antibacterialmente eficaz de um composto junto com um veìculo farmaceuticamente aceitável, e, método de preparação de um composto

Info

Publication number
BRPI0607701A2
BRPI0607701A2 BRPI0607701-3A BRPI0607701A BRPI0607701A2 BR PI0607701 A2 BRPI0607701 A2 BR PI0607701A2 BR PI0607701 A BRPI0607701 A BR PI0607701A BR PI0607701 A2 BRPI0607701 A2 BR PI0607701A2
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutically acceptable
solvate
ester
pharmaceutical composition
Prior art date
Application number
BRPI0607701-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Daniel Chu
Zhi-Jie Ni
John Jian-Xin Wang
Yaohui Lei
Yu Bai
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Publication of BRPI0607701A2 publication Critical patent/BRPI0607701A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BRPI0607701-3A 2005-02-28 2006-02-27 composto ou um sal, éster, solvato, estereoisÈmero, tautÈmero ou pró-droga farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de uma quantidade antibacterialmente eficaz de um composto junto com um veìculo farmaceuticamente aceitável, e, método de preparação de um composto BRPI0607701A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65763605P 2005-02-28 2005-02-28
PCT/US2006/007021 WO2006093933A2 (en) 2005-02-28 2006-02-27 Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity

Publications (1)

Publication Number Publication Date
BRPI0607701A2 true BRPI0607701A2 (pt) 2009-11-03

Family

ID=36941722

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0607701-3A BRPI0607701A2 (pt) 2005-02-28 2006-02-27 composto ou um sal, éster, solvato, estereoisÈmero, tautÈmero ou pró-droga farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de uma quantidade antibacterialmente eficaz de um composto junto com um veìculo farmaceuticamente aceitável, e, método de preparação de um composto

Country Status (7)

Country Link
US (2) US7368422B2 (https=)
EP (1) EP1858908A4 (https=)
JP (2) JP2008531701A (https=)
AU (1) AU2006218743A1 (https=)
BR (1) BRPI0607701A2 (https=)
CA (1) CA2599336A1 (https=)
WO (1) WO2006093933A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2588285A1 (en) 2004-11-29 2006-06-01 National University Corporation Nagoya University Glycopeptide antibiotic monomer derivatives
US7368422B2 (en) * 2005-02-28 2008-05-06 Novartis Vaccines And Diagnostics Inc. Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
US7632918B2 (en) * 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
US20070185015A1 (en) * 2005-02-28 2007-08-09 Chiron Corporation and North China Pharmaceutical Corporation Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity
TW200808818A (en) 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
GB2449156B8 (en) * 2007-05-08 2010-06-02 Lead Therapeutics Inc Semi-synthetic glycopeptides with antibacterial activity.
CN101959849A (zh) * 2007-12-26 2011-01-26 利德治疗公司 作为抗菌剂的新型半合成糖肽
US20100105607A1 (en) * 2008-10-24 2010-04-29 Lead Therapeutics, Inc. Novel semi-synthetic glycopeptides as antibacterial agents
GB2465863A (en) * 2008-12-05 2010-06-09 Lead Therapeutics Inc Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections
JP5907880B2 (ja) 2009-11-13 2016-04-26 ベックマン コールター， インコーポレイテッド クラスタリングを用いて生物学的持続状態の存在を検出するためのシステムおよび方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692327A (en) * 1984-09-06 1987-09-08 Fujimori Kogyo Co., Inc. Laminated film for packaging
US5500410A (en) * 1989-03-29 1996-03-19 Gruppo Lepetit S.P.A. Substituted alkylamide derivatives of teicoplanin
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5488131A (en) 1994-03-23 1996-01-30 California Institute Of Technology Synthesis of compounds with predetermined chirality
US5919756A (en) * 1996-06-28 1999-07-06 Eli Lilly And Company Amides
DE69908819T2 (de) * 1998-12-23 2004-05-06 Theravance, Inc., South San Francisco Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten
US6699836B2 (en) * 1999-04-02 2004-03-02 The Trustees Of Princeton University Vancomycin analogs
AU5029700A (en) 1999-05-19 2000-12-05 Merck & Co., Inc. Glycopeptide antibacterial compounds, compositions containing same and methods of using same
US20030008812A1 (en) 2001-02-02 2003-01-09 Christensen Burton G. Glycopeptide derivatives
US7348309B2 (en) 2001-03-30 2008-03-25 Wisconsin Alumni Research Foundation Glycorandomization and production of novel vancomycin analogs
EP1534316A2 (en) 2002-08-30 2005-06-01 K.U. Leuven Research and Development Glycopeptide antibiotics and semisynthetic derivatives thereof and their use as antiviral agents
AU2003287605A1 (en) 2002-11-12 2004-06-03 Enzon Pharmaceuticals, Inc. Polymeric prodrugs of vancomycin
US7521418B2 (en) * 2003-05-27 2009-04-21 Theravance, Inc. Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent
US7368422B2 (en) * 2005-02-28 2008-05-06 Novartis Vaccines And Diagnostics Inc. Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
US7632918B2 (en) 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity

Also Published As

Publication number Publication date
EP1858908A2 (en) 2007-11-28
US20080214444A1 (en) 2008-09-04
AU2006218743A1 (en) 2006-09-08
WO2006093933A3 (en) 2007-03-08
US20070021328A1 (en) 2007-01-25
JP2009102445A (ja) 2009-05-14
WO2006093933A2 (en) 2006-09-08
US7368422B2 (en) 2008-05-06
AU2006218743A8 (en) 2008-04-17
CA2599336A1 (en) 2006-09-08
EP1858908A4 (en) 2010-01-27
JP2008531701A (ja) 2008-08-14

Similar Documents

Publication Publication Date Title
BR112022012641A2 (pt) Compostos tricíclicos substituídos
UA96964C2 (ru) Соединения полициклической мочевины с антибактериальными свойствами
MX2007010072A (es) Derivados de piperidina antibacterianos.
BRPI0720551A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, e, uso do mesmo, método para o tratamento de câncer, processos para a preparação de uma composição farmacêutica e de um composto ou de um sal farmaceuticamente aceitável do mesmo
SG153833A1 (en) Methods of treatment of endobronchial infections
IL165715A0 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
WO2004062601A3 (en) Antibacterial agents
BR112012013431A8 (pt) composto, composição farmacêutica e seu uso
BRPI0720220B8 (pt) derivado de quinolina, sua composição farmacêutica, seu uso, seu processo de preparação, combinação e produto compreendendo o mesmo
DE60331056D1 (de) 6-11 bicyclische ketolidderivate
BRPI0607702A2 (pt) composto, composição farmacêutica, uso do referido composto, e método de preparação de um composto
WO2009046314A3 (en) Moenomycin analogs, methods of synthesis, and uses thereof
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
BR112014003063A2 (pt) "3,4-di-hidro-1h-[1,8]naftiridinonas substituídas com ciclopenta[c]pirrol antibacterianas, composição farmacêutica compreendendo os referidos compostos, processos para preparação destes e uso".
BRPI0618479A2 (pt) pirrolpiridinas composição farmacêutica que as contém
ATE388153T1 (de) Quervernetzte glycopeptid-cephalosporin- antibiotika
WO2004011477A3 (en) 6,11-4-carbon bridged ketolides
BRPI0607701A2 (pt) composto ou um sal, éster, solvato, estereoisÈmero, tautÈmero ou pró-droga farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de uma quantidade antibacterialmente eficaz de um composto junto com um veìculo farmaceuticamente aceitável, e, método de preparação de um composto
ATE450540T1 (de) Quervernetzte glycopeptid-cephalosporin- antibiotika
WO2007138112A3 (en) Compounds that interact with ion channels, in particular with ion channels from the kv family
WO2007071965A3 (en) Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines
WO2008038092A3 (en) Substituted piperidinophenyl oxazolidinones
BRPI0607695A2 (pt) composto ou um sal, éster, solvato, estereoisÈmero, tautÈmero ou pró-droga farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos de tratamento de um mamìfero, e para preparar um composto
AR064152A1 (es) Derivados de quinolina antibacterianos,composiciones farmaceuticas que los contienen y metodo de preparacion.
AR066345A1 (es) Glucopeptidos semisinteticos con actividad antibacteriana

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012.